Editorial: Novel diagnostic and therapeutic strategies for retinal diseases, volume II

(PVR), macular degeneration, and retinitis pigmentosa (RP), can lead to blindness without timely treatment. Vascular endothelial growth factor (VEGF) has been identified as a key promoting vascular leakage angiogenesis, making neutralization of VEGF the first-line therapy for ischemic retinopathies such DR retinal occlusions. However, not all patients with these respond anti-VEGF therapy, necessitating exploration novel treatments angiogenesisrelated diseases. Molecular genetics only helped in clarifying diagnoses but also enabled treatment inherited This Research Topic aims identify new therapeutic approaches variety diseases, including DR, occlusions, tear, detachment, epiretinal membrane, hole, pigmentosa. Their analysis provided valuable information global researchers, facilitating future collaborations tracking cutting-edge progress.Collectively, this collection articles emphasizes need further diagnostic